NCT00029731View on ClinicalTrials.gov

Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

July 31, 2005

Conditions
Anemia, Sickle CellPneumonia
Interventions
DRUG

Arginine hydrochloride

Trial Locations (1)

94609

Children's Hospital Oakland, Oakland

All Listed Sponsors
lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT00029731 - Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients | Biotech Hunter | Biotech Hunter